Oxford scientists: these are final steps we’re taking to get our coronavirus vaccine approved
REBECCA ASHFIELD, Senior Project Manager, Jenner Institute, University of Oxford PEDRO FOLEGATTI, Clinical Research Fellow at the Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, and PhD Candidate in Clinical Medicine, University of Oxford OF the hundreds of potential COVID-19 vaccines in development, six are in the final stages of testing, known as phase 3 clinical trials. One of these – ChAdOx1 nCoV-19 – is the vaccine we’re developing at the University of Oxford. To be approved, vaccines need to go through multiple rounds of testing to show that they’re safe and effective. A combined phase 1 and phase…